Buscar
Mostrando ítems 1-10 de 43
An evaluation of ticagrelor for the treatment of sickle cell anemia
(Expert Reviews, 2020)
Angiographic and electrocardiographic parameters of myocardial reperfusion in angioplasty of patients with ST elevation acute myocardial infarction loaded with ticagrelor or clopidogrel (MICAMI-TICLO trial)
(2014)
Introduction Ticagrelor has been shown to improve outcomes in patients with ACS. However, the effects of this drug on parameters of microvascular flow in patients presenting with ST-segment elevation myocardial infarction ...
Reacción de hipersensibilidad a ticagrelor
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2020-04-06)
Planejamento experimental aplicado aos estudos de degradação forçada do fármaco Ticagrelor
(Universidade Federal de São CarlosUFSCarPrograma de Pós-Graduação em Química - PPGQCâmpus São Carlos, 2020-08-31)
Stability indicating tests are an essential part during pharmaceutical drug production, besides being a mandatory step for the regulation and approval from the regulatory agencies. Forced degradation consist of an exposure ...
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial
(American Medical Association, 2018)
Importance: The bleeding safety of ticagrelor in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy remains uncertain. Objective: To evaluate the short-term safety of ticagrelor when compared ...
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial
(Elsevier, 2019)
Background: The efficacy of ticagrelor in the long-term post–ST-segment elevation myocardial infarction (STEMI)treated with fibrinolytic therapy remains uncertain. Objectives: The purpose of this study was to evaluate the ...
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
(OXFORD UNIV PRESS, 2010)
Patients with diabetes mellitus (DM) have high platelet reactivity and are at increased risk of ischaemic events and bleeding post-acute coronary syndromes (ACS). In the PLATelet inhibition and patient Outcomes (PLATO) ...
Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor Insights From the Platelet Inhibition and Patient Outcomes Trial
(LIPPINCOTT WILLIAMS & WILKINSPHILADELPHIA, 2012)
Background-The clinical significance of the interaction between clopidogrel and proton pump inhibitors (PPIs) remains unclear. Methods and Results-We examined the relationship between PPI use and 1-year cardiovascular ...
Drogas antiplaquetarias de utilización en Síndrome Coronario Agudo
(Asociación Costarricense de Cardiología, 2019)
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack
(LIPPINCOTT WILLIAMS & WILKINSPHILADELPHIA, 2012)
Background-Patients with acute coronary syndromes and history of stroke or transient ischemic attack (TIA) have an increased rate of recurrent cardiac events and intracranial hemorrhages. Methods and Results-We evaluated ...